Tomoki Naoe

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Guoqiang Chen, Xuegeng Shi, Wei Tang et al. · PubMed · 1997 · 803 citations

Medicine, Hematology, Oncology +14

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations

Medicine, Genetics, Oncology +16

let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells

Yukihiro Akao, Yoshihito Nakagawa, Tomoki Naoe · Biological and Pharmaceutical Bulletin · 2006 · 629 citations · Full text

Medicine, Molecular Biology, Oncology +17

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

Fumihiko Hayakawa, Masayuki Towatari, Hitoshi Kiyoi et al. · Oncogene · 2000 · 576 citations

Life Sciences, Cell Biology, Genetics +8

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

Takashi Oyama, Kazuhito Yamamoto, Naoko Asano et al. · Clinical Cancer Research · 2007 · 459 citations

Medicine, Hematology, Pathology +15